© 2024 Connecticut Public

FCC Public Inspection Files:
WEDH · WEDN · WEDW · WEDY
WECS · WEDW-FM · WNPR · WPKT · WRLI-FM · WVOF
Public Files Contact · ATSC 3.0 FAQ
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
Cancer Answers is hosted by Dr. Anees Chagpar, Associate Professor of Surgical Oncology and Director of The Breast Center at Smilow Cancer Hospital at Yale-New Haven Hospital, and Dr. Francine Foss, Professor of Medical Oncology. The show features a guest cancer specialist who will share the most recent advances in cancer therapy and respond to listeners questions. Myths, facts and advances in cancer diagnosis and treatment are discussed, with a different focus eachweek. Nationally acclaimed specialists in various types of cancer research, diagnosis, and treatment discuss common misconceptions about the disease and respond to questions from the community.Listeners can submit questions to be answered on the program at canceranswers@yale.edu or by leaving a message at (888) 234-4YCC. As a resource, archived programs from 2006 through the present are available in both audio and written versions on the Yale Cancer Center website.

Promising Drug for Depression

Erik Charlton

According to the Connecticut Health Investigative Team, researchers at the Yale School of Medicine are touting  Ketamine as “the magic drug,” able to ease severe depression and suicidal thoughts in patients within a matter of hours.
 
Dr. John Krystal, chair of the school’s Department of Psychiatry and chief of psychiatry at Yale-New Haven Hospital, says that although Ketamine is currently used primarily as an anesthetic and for certain types of pain, it shows early promise as a treatment for depression.
Even though Ketamine is a very short-acting medication, a matter of minutes to an hour or two, the antidepressant effects that emerge from ketamine emerge very quickly, within three or four hours and last between a few days to a few weeks from a single injection of Ketamine.  

Despite the promise of Ketamine’s use in people with depression who are resistant to more commonly prescribed anti-depressants, such as Zoloft and Prozac, Dr. Krystal says doctors still aren’t sure exactly how to incorporate Ketamine into treatment. Doctors hope to find a dose that produces beneficial antidepressant effects without the symptoms of psychosis that can result with higher doses of the drug. 
 
Although in the early stage of study, researchers are also experimenting with other uses for Ketamine, such as for post-traumatic stress disorder and alcohol addiction. Dr. Krystal says that people with a family history of alcoholism may actually have a more pronounced antidepressant effect to Ketamine.
 
You can read the C-HIT story at C slash hit dot new haven independent dot org.
 
 
 

Ray Hardman is Connecticut Public’s Arts and Culture Reporter. He is the host of CPTV’s Emmy-nominated original series Where Art Thou? Listeners to Connecticut Public Radio may know Ray as the local voice of Morning Edition, and later of All Things Considered.

Stand up for civility

This news story is funded in large part by Connecticut Public’s Members — listeners, viewers, and readers like you who value fact-based journalism and trustworthy information.

We hope their support inspires you to donate so that we can continue telling stories that inform, educate, and inspire you and your neighbors. As a community-supported public media service, Connecticut Public has relied on donor support for more than 50 years.

Your donation today will allow us to continue this work on your behalf. Give today at any amount and join the 50,000 members who are building a better—and more civil—Connecticut to live, work, and play.